Management of erectile dysfunction secondary to treatment for localized prostate cancer

Cancer Control

Volumn 8, Issue 6, 2001, Pages 540-545

  Telöken, Cláudio ^a  

^a UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; PROSTAGLANDIN E1; SILDENAFIL;

BRACHYTHERAPY; CANCER RADIOTHERAPY; COMORBIDITY; ERECTILE DYSFUNCTION; IMPOTENCE; PATHOPHYSIOLOGY; PATIENT SATISFACTION; PENIS PROSTHESIS; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; REVIEW; SEXUAL FUNCTION; SURGICAL TECHNIQUE;

EID: 0035685856     PISSN: 10732748     EISSN: None     Source Type: Journal    
DOI: 10.1177/107327480100800609     Document Type: Review

References (44)

1. Development panel on impotence
2. Impotence and its medical psychosocial correlates: Results of the Massachusetts Male Aging Study
3. Erectile dysfunction
4. Sexual dysfunction in cancer patients
5. The development of erectile dysfunction in men treated for prostate cancer
6. Erectile function and quality of life after interstitial radiation therapy for prostate cancer
7. I125 prostate brachytherapy: Short-term results of the first 150 patients in Israel
8. Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer
9. Short-term sexual function after prostate brachytherapy
10. Sexual dysfunction after radical radiation therapy for prostate cancer: A prospective evaluation
11. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer
12. Potency preservation after three-dimensional conformal radiotherapy for prostate cancer: Prelminary results
13. Improving the preservation of erectile function after external-beam radiation therapy for prostate cancer
14. Potency after permanent prostate brachytherapy for localized prostate cancer
15. Health-related quality-of- life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer
16. Image-guided prostate cryosurgery: State of the art
17. Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies
18. Comparative quality-of-life analysis after radical prostatectomy or external beam radiation for localized prostate cancer
19. Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life: A structured debate
20. Differences in sexual function and quality of life after nerve sparing and nonnerve sparing radical retropubic prostatectomy
21. Patient-reported urinary continence and sexual function after anatomic radical prostatectomy
22. Effect of radical retropubic prostatectomy on erectile function, evaluated before and after surgery using colour Doppler ultrasonography and nocturnal penile tumescence monitoring
23. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The Prostate Cancer Outcomes Study
24. Multicenter patient self-reporting questionnaire on impotence, incontinence and stricture after radical prostatectomy
25. Quality of life after radical prostatectomy
26. Factors predicting recovery of erections after radical prostatectomy
27. Update on impact of moderate dose of adjuvant radiation on urinary continence and sexual potency in prostate cancer patients treated with nerve-sparing prostatectomy
28. Sexual function and bother after radical prostatectomy or radiation for prostate cancer: Multivariate quality-of-life analysis from CaPSURE
29. Clinical efficacy of sildenafil citrate based on etiology and response to prior treatment
30. Comparative evaluation of treatments for erectile dysfunction in patients with prostate cancer after radical retropublic prostatectomy
31. Erectile dysfunction following radical therapy for prostate cancer
32. Efficacy of oral sildenafil in patients with erectile dysfunction after radiotherapy for carcinoma of the prostate
33. Treatment of erectile dysfunction after radical prostatectomy with sildenafil citrate (Viagra)
34. Prospective pilot study sildenafil for treatment of postradiotherapy erectile dysfunction in patients with prostate cancer
35. Efficacy of sildenafil citrate in prostate brachytherapy patients with erectile dysfunction
36. Treatment of erectile dysfunction with sildenafil citrate (Viagra) after radiation therapy for prostate cancer
37. Oral drug therapy for erectile dysfunction
38. Effectiveness of combination therapy of MUSE and Viagra in the salvage of erectile dysfunction patients desiring noninvasive therapy: 18-Month follow-up
39. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: Results of a prospective, randomized trial
40. Erectile dysfunction after radical prostatectomy: Value of preoperative programming of intracavernous injections
41. Bilateral nerve graft during radical retropubic prostatectomy: 1-Year follow up
42. Erectile function after radical prostatectomy
43. Sexual performance and satisfaction with penile prosthesis in impotence of various etiologies